SG/CALL/INTUITIVE SURGICAL/260/0.1/21.06.24 Stock

Warrant

DE000SQ1KHC7

Market Closed - Deutsche Boerse AG 15:41:47 2024-05-31 EDT
12.89 EUR -2.50% Intraday chart for SG/CALL/INTUITIVE SURGICAL/260/0.1/21.06.24
1 month+20.47%
3 months+4.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 12.89 -2.50%
24-05-30 13.22 +2.72%
24-05-29 12.87 -0.85%
24-05-28 12.98 -2.26%
24-05-27 13.28 -0.82%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:41 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying INTUITIVE SURGICAL, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ1KHC
ISINDE000SQ1KHC7
Date issued 2022-10-06
Strike 260 $
Maturity 2024-06-21 (19 Days)
Parity 10 : 1
Emission price 3.08
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 13.75
Lowest since issue 2.42
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 1.547
Difference Strike -142.1 $
Difference Strike %-54.66%
Intrinsic value 13.10

Company Profile

Intuitive Surgical, Inc. specializes in the design, manufacturing, and marketing of robotic surgical assistance video systems. The systems consist of a surgical console, arm, remote-controlled endoscope, and 3D visual immersion system. Net sales break down by activity as follows: - sale of instruments and accessories (60%): primarily wrist cuffs; - sale of robotic systems (23.6%): systems marketed under the da Vinci brand (1,370 units sold in 2023) and intended primarily for urological, cardio-thoracic, and gynecological surgeries; - installation and training services (16.4%). The United States accounts for 65.8% of net sales.
Sector
-
More about the company

Ratings for Intuitive Surgical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Intuitive Surgical, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
402.1 USD
Average target price
423.6 USD
Spread / Average Target
+5.33%
Consensus